Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409825 · ClinicalTrials.gov registry record · Phase 2
Study of Pharmacology of 17-OHPC in Pregnancy
A Phase 2 study of Pregnancy, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
- 4
- Study locations
NCT00409825: Completed Phase 2 study of Pregnancy, sponsored by University of Pittsburgh.
NCT00409825 is a Phase 2 study of Pregnancy that has completed, run by University of Pittsburgh. The registered enrollment target is 61 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00409825, a Phase 2 study of Pregnancy, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
- 4
- Study locations
Study Summary
We are examining the pharmacology of 17-OHPC in pregnancy, specifically between the second and third trimesters.
Primary Outcome
Change in the area under the concentration vs. time curve in the second and third trimesters of pregnancy. We compared AUC at each PK study visit. Measurements were obtained at 0, 1, 2, 3, 4, 5, 6, 7 days.
Conditions Studied
Interventions
- DRUG 17-OHPC
- PROCEDURE Blood Draws
Study Locations (4)
District of Columbia
- Georgetown University - Washington D.C.
Pennsylvania
- Magee-Womens Hospital of University of Pittsburgh Medical Center - Pittsburgh
Texas
- University of Texas - Galveston
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2006-03 |
| Est. Completion | 2014-02 |
| Phase | Phase 2 |
What the finished NCT00409825 record still lists
NCT00409825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which 17-OHPC is the first listed.
NCT00409825 reports a single indexed study location in District of Columbia, Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT00409825 about?
NCT00409825 is a clinical study titled "Study of Pharmacology of 17-OHPC in Pregnancy". We are examining the pharmacology of 17-OHPC in pregnancy, specifically between the second and third trimesters.
What is the current status of trial NCT00409825?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2006-03. Estimated completion is 2014-02.
What conditions does trial NCT00409825 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT00409825?
The interventions under investigation include: 17-OHPC (DRUG), Blood Draws (PROCEDURE).
Who is sponsoring clinical trial NCT00409825?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00409825 being conducted?
This trial has 4 study locations across District of Columbia, Pennsylvania, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00409825's enrollment target sits among peer trials
61 142nd of 191 higher than 49 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
RECRUITING · Phase 2
-
Healthy4Baby: Preventing Postpartum Weight Retention Among Low-Income, Black Women
COMPLETED · Phase 2
-
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
COMPLETED · Phase 2
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia